96
Participants
Start Date
April 1, 2007
Primary Completion Date
June 1, 2008
Study Completion Date
June 1, 2008
ecallantide
dose of 30 mg (10 mg/ml) given as 3 subcutaneous injections.
Phosphate Buffer Saline (PBS), pH 7.0
given as three 1mL subcutaneous injections.
Jordan University Hospital, Amman
Winthrop University Hospital, Mineola
Childrens Hospital of Pittsburgh, Pittsburgh
Penn State Milton S. Hershey Medical Center, Hershey
Valley Clinical Research Center, Easton
Asthma Allergy and Pulmonary Associates, Philadelphia
Christiana Hospital, Newark
Georgetown University Hospital, Washington D.C.
Institute for Asthma and Allergy, Wheaton
Clinical Research Associates of Tidewater, Norfolk
Allergy Partners of Western North Carolina, Asheville
Family Allergy & Asthma Center, PC, Atlanta
Allergy Center of Brookstone, Columbus
University of Miami, General Clinical Research Center, Miami
Roberson Allergy and Asthma, West Palm Beach
University of South Florida, Tampa
Highlands Allergy and Asthma Center, PC, Bristol
Optimed Research, LLC, Columbus
University of Cincinnati, Cincinnati
Muncie Allergy Center, Muncie
Asthma and Allergy Institute of Michigan, Clinton Township
Respiratory Medicine Research Institute of Michigan, PLC, Ypsilanti
University Consultants in Allergy and Immunology, Chicago
Kansas City Allergy & Asthma, Overland Park
Arkansas Children's Hospital, Little Rock
Little Rock Allergy & Asthma Clinic, Little Rock
AARA Research Center, Dallas
Baylor Clinic, Baylor College of Medicine, Houston
The Paull Allergy and Asthma Clinic, P.A., Bryan
Asthma and Allergy Associates, P.C., Colorado Springs
Aaron J. Davis, Scottsdale
Allergy Partners of Albuquerque, Albuquerque
Nevada Access to Research and Education Society, Las Vegas
University of Nevada School of Medicine, Reno
Jacob Offenberger, Granada Hills
Alta Bates Comprehensive Cancer Center, Berkeley
Pacific Coast Allergy, Crescent City
Puget Sound Allergy, Asthma, & Immunology, Tacoma
UCLA David Geffen School of Medicine, Department of Medicine, Los Angeles
Brigham and Women's Hospital, Chestnut Hill
UMDNJ-New Jersey Medical School, Newark
University of Texas Medical School, Galveston
University of Utah, Salt Lake City
Allergy and Asthma Research Center, Ottawa
University of Toronto, Toronto
Lead Sponsor
Shire
INDUSTRY